Chile: Carlyle Group makes new offer for EMV – Founders ask for vote to be delayed
US-based investors The Carlyle Group have been outed as interested parties in snatching up the assets of healthcare chain Isapre-Masvida, creating a rift within the latter’s board, which was in advanced talks with rival Nexus.
Carlyle Group, which owns local companies Doggis, Juan Maestro and Mamut, has said it will formally communicate their offer to EMV’s directors, seeking to take over Masvida, Isapre and the entirety of their passive and active assets and clinics, with a value estimated at $150 bn pesos (approx. $232.4 million US), to be paid in cash.
The proposal arrives at a tense time for EMV’s board, which is divided over those who have pushed for the Nexus deal and board members from the Concepción region, who have not looked kindly on Nexus’ offer. This partly due to what they consider a low offer of $35 bn ($54 million US) for the Mas Vida affiliates portfolio, as well as for the short timetable and tight deadline given to respond and study the offer.
Full Content: Pulso
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI